NEW YORK Johnson & Johnson has confirmed putting its global media business into play and inviting its incumbents to defend. The review was expected.
The New Brunswick, N.J., company spends more than $2 billion annually in U.S. measured media and approximately $3 billion globally, per sources.
In a statement, J&J said, "The recent acquisition of Pfizer Consumer Healthcare created an opportunity to re-evaluate our media agency relationships and enhance the ability of our brands to effectively communicate and leverage investment across the rapidly changing and increasingly diverse media landscape."
Kim Kadlec, vp, worldwide media, and Brian Perkins, vp, corporate affairs, are among the key client decision makers overseeing the competition.
Media incumbents include Interpublic Group's Initiative and Universal McCann, Omnicom Group's OMD and WPP Group's MindShare.
The IPG shops late Friday said they intend to participate in the contest, which is slated to finish up in mid-summer. The client's creative assignments are not impacted by the media review.
J&J last November cut ties with Aegis Group's Carat, which had been the lead agency on the Pfizer Consumer Healthcare portion of the business.
The company's portfolio of well-known consumer brands includes Aveeno, Band-Aid, Neutrogena, Splenda and Tylenol.